A 54-year-old Japanese woman was admitted to our ward because of recurrent chest pain at rest for 2 months. She had been treated with nivolumab, an immune checkpoint inhibitor for inoperable advanced hypopharyngeal cancer for 21 months. She had no chest pain after cessation of nivolumab treatment. Cardiac catheterization confirmed the presence of vasospastic angina. Benidipine 8 mg was started, and she had no chest pain even after resuming therapy with nivolumab. Vasospastic angina is an adverse effect of nivolumab.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334223 | PMC |
| http://dx.doi.org/10.2169/internalmedicine.8540-21 | DOI Listing |
Publication Analysis
Top Keywords
vasospastic angina
12
chest pain
12
angina immune-related
4
immune-related adverse
4
adverse event
4
event 54-year-old
4
54-year-old japanese
4
japanese woman
4
woman admitted
4
admitted ward
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!